You have 9 free searches left this month | for more free features.

Newark (1)

Multiple Sclerosis (1)

Relapsing Remitting Multiple Sclerosis (1)

Completed (1)

Terminated (1)

phase 4 (2)

Teva Branded Pharmaceutical Products R&D, Inc. (1)

University of Medicine and Dentistry of New Jersey (1)

betaseron (2)

copaxone (1)

glatiramer acetate (1)

rebif (1)

drug (2)

Industry (1)

Other (1)

Interventional (2)

betaseron

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Completed

Oct 18, 2021

Terminated

Oct 14, 2010